Aurobindo Pharma stock has rallied 90 percent from the March 2020 lows. The company is scheduled to report its Q3FY21 earnings tomorrow (February 10).
CNBC-TV18 expects a revenue growth of around 9 percent, margins at 21 percent and profit up around 16 percent.
Watch video for more.
(Edited by : Priyanka Rathi)